Home Health and Hospice Investment Banks – 2026 Review
Our research team evaluated 25+ investment banks active in the home health and hospice M&A sector. We chose seven firms for further exploration, based on market reputation and our analysis of publicly available information, including the following:
Documented Deal Experience: Publicly disclosed transaction experience in healthcare services.
Visible Buyer Exposure: Demonstrated involvement with active PE sponsors, strategics, and health systems shown in announced transactions.
Consistency of Deal Size & Transaction Type: Track record of transactions aligning with typical home health and hospice platform and add-on deal sizes.
Disclaimer: This analysis reflects our opinion based on publicly available information and market research. It is for informational purposes only, does not constitute investment advice, and does not guarantee outcomes. Readers should conduct their own due diligence when selecting an investment bank.
Spotlight – Healthcare Investment Banks
| Firm | Sector Depth | Buyer Access | Deal Relevance |
|---|---|---|---|
| FOCUS Investment Banking | Deep healthcare specialization | Active PE & strategic buyers | Strong lower middle-market fit ($20M to $200M sweet spot) |
| Ziegler | Longstanding healthcare focus | Broad institutional relationships | General healthcare services experience, with strong reputation in long-term care |
| Cain Brothers | Broad healthcare exposure | Large institutional buyers | Larger, complex transactions |
| Houlihan Lokey | Multi-segment healthcare coverage | Global PE and strategics | Upper-middle-market focus, especially on private equity groups |
| Piper Sandler | Services & healthcare tech | Global PE and strategics | Scaled healthcare businesses |
| TripleTree | Services & HCIT focus | Global PE and strategics | Very strong in tech-enabled healthcare, with growing services practice |
| SVB Securities | Innovation-driven healthcare | Venture & growth equity | Growth-stage companies |
Detailed Reviews
1. FOCUS Investment Banking
FOCUS Investment Banking boasts strong alignment with lower middle market sellers, often privately owned companies valued in the $20M to $200M range. Healthcare Sector Depth: Deep specialization across healthcare services and physician-led businesses.
Buyer Network & Capital Access: Strong relationships with active private equity sponsors and strategic acquirers focused on quality platforms.
Deal Relevance: Strong fit for founder-owned businesses navigating platform vs add-on dynamics.
| Summary of Online Reviews |
|---|
|
2. Ziegler
Ziegler is well-regarded for its healthcare sector knowledge and longstanding presence in the industry. The firm performs particularly well in advisory roles where sector familiarity and institutional credibility are key.
Healthcare Sector Depth: Strong understanding of healthcare services and provider models.
Buyer Network & Capital Access: Broad relationships across institutional buyers.
Deal Relevance: More variable fit depending on transaction size and structure.
| Summary of Online Reviews |
|---|
|
Clients often point to Ziegler’s deep industry expertise and steady execution across healthcare transactions. Reviews mention a strong understanding of sector dynamics, thoughtful guidance throughout the process, and a consistent ability to manage transactions without unnecessary disruption. |
3. Cain Brothers
Cain Brothers brings institutional experience and a strong healthcare brand, with strengths in larger or more complex healthcare transactions. The firm is often aligned with upper-middle-market engagements.
Healthcare Sector Depth: Broad healthcare exposure.
Buyer Network & Capital Access: Strong institutional relationships.
Deal Relevance: Less focused on lower middle-market transactions.
| Summary of Online Reviews |
|---|
|
Clients often describe Cain Brothers as “industry insiders” who bring “deep industry knowledge” and a “holistic viewpoint” that clarifies strategic options. |
4. Houlihan Lokey (Healthcare Group)
Houlihan Lokey’s healthcare group operates primarily at the upper end of the middle market in large, complex transactions. The firm is often engaged where scale and or capital structure complexity are key components of a transaction. Houlihan is a common choice for PE groups seeking an advisor to sell their portfolio companies.
Healthcare Sector Depth: Broad exposure across healthcare services, life sciences, and provider-adjacent businesses.
Buyer Network & Capital Access: Extensive relationships with global private equity and strategic buyers.
Deal Relevance: Best aligned with larger, more complex transactions rather than lower middle-market healthcare.
| Summary of Online Reviews |
|---|
|
Clients often describe Houlihan Lokey’s healthcare team as highly effective at driving competitive outcomes, frequently noting “outstanding results and a superior service level.” |
5. Piper Sandler (Healthcare Investment Banking)
Piper Sandler brings a strong research-backed perspective to healthcare advisory, leveraging its public-market insights in transaction execution.
Healthcare Sector Depth: Strong coverage across healthcare services and healthcare technology.
Buyer Network & Capital Access: Solid access to strategic buyers and sponsor-backed platforms.
Deal Relevance: Better suited for scaled businesses than smaller, founder-led companies.
| Summary of Online Reviews |
|---|
|
Clients and observers often reference Piper Sandler’s best-in-class sector knowledge and high-touch deal teams, noting that its bankers are deeply involved in both strategic positioning and day-to-day execution. |
6. TripleTree
TripleTree is known for its focus on healthcare services and healthcare IT, with a process designed to emphasize growth narratives and technology-enabled models. The firm tends to perform best when its assets are differentiated and positioned for strategic buyers.
Healthcare Sector Depth: Concentrated experience in healthcare services and HCIT.
Buyer Network & Capital Access: Strong relationships with growth-oriented sponsors and strategics.
Deal Relevance: Best fit for healthcare businesses with scale and growth momentum.
| Summary of Online Reviews |
|---|
|
Reviews often highlight access to venture and growth equity investors, familiarity with innovation-driven business models, and the ability to navigate capital markets conversations alongside strategic advisory. |
7. SVB Securities (Healthcare Group)
SVB Securities’ healthcare advisory work is closely tied to innovation-driven and venture-backed businesses. The firm’s strengths lie in capital markets connectivity and growth-stage advisory rather than traditional middle-market healthcare exits.
Healthcare Sector Depth: Strong in healthtech, biotech, and innovation-driven healthcare models.
Buyer Network & Capital Access: Deep relationships with venture and growth equity investors.
Deal Relevance: Limited alignment with established lower middle-market healthcare services companies.
| Summary of Online Reviews |
|---|
|
Customers of SVB Securities frequently point to the firm’s strong connectivity within growth-stage healthcare and life sciences ecosystems. Reviews often highlight access to venture and growth equity investors and familiarity with innovation-driven business models. |
Contact Us
If you’d like to learn more about our healthcare investment banking services, reach out here.
